MetaADEDB 2.0 @ LMMD
Natriuretic Peptide, Brain
(KSFAMFKTRGJQKV-UDZSTSFQSA-N)
Structure
SMILES
NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC1N=CN=C1)CCCNC(=N)N)CCCNC(=N)N)CC(C)C)C(C)C)NC(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)N)CCCCN)CCSC)CCC(=O)N)CO)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N1)CC(C)C)CO)CO)CO)CO)[C@H](CC)C)CCCNC(=N)N
Molecular Formula:
C143H244N50O42S4
Molecular Weight:
3464.040
Log P:
-2.5023
Hydrogen Bond Acceptor:
96
Hydrogen Bond Donor:
55
TPSA:
1609.98
CAS Number(s):
N/A
Synonym(s)
1.
Natriuretic Peptide, Brain
2.
Brain Natriuretic Peptide
3.
Nesiritide
4.
B-Type Natriuretic Peptide
5.
BNP Gene Product
6.
BNP-32
7.
Brain Natriuretic Peptide-32
8.
Natrecor
9.
Natriuretic Factor-32
10.
Natriuretic Peptide Type-B
11.
Type-B Natriuretic Peptide
12.
Ventricular Natriuretic Peptide, B-type
13.
BNP 32
14.
Brain Natriuretic Peptide 32
15.
Natriuretic Factor 32
16.
Natriuretic Peptide Type B
17.
Natriuretic Peptide, B-Type
18.
Natriuretic Peptide, Type-B
19.
Natriuretic Peptide-32, Brain
20.
Peptide, Brain Natriuretic
21.
Peptide-32, Brain Natriuretic
22.
Type B Natriuretic Peptide
23.
Ventricular Natriuretic Peptide, B type
External Link(s)
MeSHD020097
PubChem Compound25081014
CHEMBLCHEMBL4071327
Therapeutic Target DatabaseD05GRY
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HypotensionFAERS: 17US FAERS
2Medication ErrorFAERS: 11US FAERS
3Blood creatinine increasedFAERS: 6US FAERS
4OverdoseFAERS: 5US FAERS
5AstheniaFAERS: 4US FAERS
6TremorFAERS: 4US FAERS
7DizzinessFAERS: 3US FAERS
8Myocardial InfarctionFAERS: 3US FAERS
9AlopeciaFAERS: 2US FAERS
10Blood glucose decreasedFAERS: 2US FAERS
11Chest PainFAERS: 2US FAERS
12Corneal lesionFAERS: 2US FAERS
13Drug ineffectiveFAERS: 2US FAERS
14Ejection Fraction DecreasedFAERS: 2US FAERS
15Ventricular arrhythmiaFAERS: 2US FAERS
16Weight decreasedFAERS: 2US FAERS
17Abdominal PainFAERS: 1US FAERS
18AnorexiaFAERS: 1US FAERS
19AnxietyFAERS: 1US FAERS
20ArthritisFAERS: 1US FAERS
21Atrial FlutterFAERS: 1US FAERS
22Back PainFAERS: 1US FAERS
23Blood sodium decreasedFAERS: 1US FAERS
24Blood urea increasedFAERS: 1US FAERS
25Cardiac ArrestFAERS: 1US FAERS
26Cold sweatFAERS: 1US FAERS
27Drug dose omissionFAERS: 1US FAERS
28Drug toxicityFAERS: 1US FAERS
29Electromechanical dissociationFAERS: 1US FAERS
30ExtravasationFAERS: 1US FAERS
31Feeling abnormalFAERS: 1US FAERS
32FlatulenceFAERS: 1US FAERS
33General physical health deteriorationFAERS: 1US FAERS
34Hepatic congestionFAERS: 1US FAERS
35HypoxiaFAERS: 1US FAERS
36Iatrogenic injuryFAERS: 1US FAERS
37Incorrect route of drug administrationFAERS: 1US FAERS
38Infusion site painFAERS: 1US FAERS
39Infusion site reactionFAERS: 1US FAERS
40Injection site extravasationFAERS: 1US FAERS
41Low Cardiac Output SyndromeFAERS: 1US FAERS
42NauseaFAERS: 1US FAERS
43PancytopeniaFAERS: 1US FAERS
44Perforated ulcerFAERS: 1US FAERS
45PneumoniaFAERS: 1US FAERS
46Post procedural complicationFAERS: 1US FAERS
47Procedural complicationFAERS: 1US FAERS
48Respiratory FailureFAERS: 1US FAERS
49SepsisFAERS: 1US FAERS
50ShockFAERS: 1US FAERS
51Stevens-Johnson SyndromeFAERS: 1US FAERS
52ThrombocytopeniaFAERS: 1US FAERS
53VertigoFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.